Diagnostic techniques for primary cutaneous melanoma

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 2, 2009, Pages 187-194

  Lien, M H ^a   Sondak, V K ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Comparative genomic hybridization; Dermoscopy; Magnetic resonance imaging; Melanoma,diagnosis; Microscopy, confocal; Tomography, X ray computed

Indexed keywords

COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL LASER MICROSCOPY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EPILUMINESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL PHOTOGRAPHY; MELANOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; TELEDERMATOLOGY;

EID: 67649589248     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Marghoob AA, Swindle LD, Moricz CZ, Sanchez Negron FA, Slue B, Halpern AC et al. Instruments and new technologies for the in vivo diagnosis of melanoma J Am Acad Dermatol 2003;777-797 (Pubitemid 37314865)
2. Garbe C, Eigentier TK. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res 2006;17:117-127
3. Barzegari M, Ghaninezhad H, Mansoori P, Taheri A, Naraghi ZS, Asgari M. Computer-aided dermoscopy for diagnosis of melanoma. BMC Dermatology 2005;5:8. (Pubitemid 41554196)
4. Elbaum M, Kopf AW, Rabinovitz HS, Langley RG, Kamino H, Mihm MC Jr et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol 2001;44:207-218 (Pubitemid 32172181)
5. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal scanning laser microscopy of human skimmelanin provides strong contrast. J Invest Dermatol 1995;104:946-952
6. Rajadhyaksha M, Gonzalez S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol 1999;113:293-303.
7. Gerger A, Hofmann-Wellenhof R, Langsenlehner U, Richtig E, Koller S, Weger W et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J Investig Dermatol 2005;124:493-498 (Pubitemid 40381570)
8. El Gammal S, Auer T, Hoffman K, Altmeyer P, Passmann C, Emmert H. High-resolution ultrasound examination of the epidermis. In: Serup J, Jemec GBE, editors. Handbook of non-invasive methods and the skin. Boca Raton (FL): CRC Press; 1995. p. 125-131
9. Hoffman K. Non ELM imaging techniques sonsography-optical coherence tomography-CT laser scanning microscopy. Melanoma Res 2001;11:29.
10. Turnbull DH, Starkoski BG, Harasiewicz KA, Semple JL, From L, Gupta AK et al. A 40-100 MHz B -scan ultrasound backscatter microscope for skin imaging. Ultrasound Med Biol 1995;21:79-88.
11. Ulrich J, Voit C. Ultrasound in dermatology:part II, ultrasound of regional lymphy node basins and subcutaneous tumours. Eur J Dermatol 2001;1:73-79 (Pubitemid 32150387)
12. Jemec GB, Gniadecka M, Ulrich J. Ultrasound in dermatology:part I, high frequency ultrasound. Eur J Dermatol 2000;6:492-497
13. Serup J, Keidling K, Fullerton A, Gniadecka M, Gniadecki R. High-frequency ultrasound examination of skin: introduction and guide. In: Serup J, Jemec GBE, editors. Handbook of non-invasive methods and the skin. Boca Raton (FL): CRC Press 1995;239-256
14. Lassau N, Spatz A, Avril MF, Tardivon A, Marguilis A, Mamelle G et al. Value of high-frequency US for preoperative assessment of skin tumors. Radiographics 1997;17:1559-1565
15. Massone C, Wurm EM, Hofmann-Wellenhof R, Soyer HP. Teledermatology: an update. Semin Cutan Med Surg 2008;27:101-105
16. Piccolo D, Smolle J, Wolf IH, Peris K, Hofmann-Wellenhof R, Dell'Eva G et al. Face-to-face diagnosis vs telediagnosis ofS pigmented skin tumors: A teledermoscopic study. Arch Dermatol 1999;135:1467-71.
17. Carli P, de Giorgi V, Chiarugi A, Nardini P, Weinstock MA, Crocetti E et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: A randomized study. J Am Acad Dermatol 2004;50:683-689
18. Berman B, Elgart GW, Burdick AE. Dermatopathology via a still-image telemedicine system: Diagnostic concordance with direct microscopy. Telemed J 1997;3:27-32. (Pubitemid 27149226)
19. Balseiro SC, Correia HR. Is olfactory detection of human cancer by dogs based on major histocompatibility complex-dependent odour components? - A possible cure and a precocious diagnosis of cancer. Medical Hypotheses 2006;66:270-272 (Pubitemid 41773899)
20. Williams H, Pembroke A. Sniffer dogs in the melanoma clinic? Lancet 1989;1:734. (Pubitemid 19089262)
21. Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R et al. Volatile markers of breast cancer in the breath. Breast J 2003;9:184-191
22. Yamada K, Walsh N, Hara H, Jimbow K, Chen H, Ito S. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases. Arch Dermatol 1992;128:491-494
23. Montag S, Frank M, Ulmer H, Wernet D, Gopel W, Rammensee HG. "Electronic nose" detects major histocompatibility complex-dependent prerenal and postrenal odor components. Proc Natl Acad Sci USA 2001;98:9249-9254
24. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatologic Therapy 2006;19:40-49
25. Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC Jr et al. Atypical Spitz nevi/sumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999;30:513-520 (Pubitemid 29218042)
26. Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol 2001;28:400-406 (Pubitemid 32756577)
27. Clark WH Jr, Hood AF, Tucher MA, Jampel RM. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol 1998;29:S1-S24. (Pubitemid 28106104)
28. Ackerman AB, Cerroni L, Kerl H. Pitfalls in histopathologic diagnosis of malignant melanoma. Philadelphia: Lea & Febiger; 1994.
29. Tronnier M, Alexander M, Neitmann M, Brinckmann J, Wolff HH. Morphologicische veranderungen in melanozytaren navi durch exogene faktoren. Hautarzt 2000;51:561-566 (Pubitemid 30629223)
30. Chen YT, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ, van der Bruggen P et al. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA 1994;91:1004. (Pubitemid 24048497)
31. Hofbauer GF, Schaefer C, Noppen C, Böni R, Kamarashev J, Nestle FO et al. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. Am J Pathol 1997,151:1549. (Pubitemid 27527917)
32. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (MART-1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998;22:976. (Pubitemid 28364497)
33. Hochberg M, Lotem M, Gimon Z, Shiloni E, Enk CD. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol 2002;146:244. (Pubitemid 34264394)
34. King R, Googe PB, Weilbaecher KN, Mihm MC Jr, Fisher DE. Micophthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 2001;25:51-57 (Pubitemid 32001832)
35. McGill GG, Hortstmann M, Widlund HG, Du J, Motyckova G, Nishimura EK et al. Bcl2 regulation by the melanocye master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002;14;109:707-718
36. King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE. Microphthalmia Transcription Factor, A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 1999;155:731-8.
37. Yaziji H, Gown AM. Immunohistochemical markers of melanocytic tumors. Int J Surg Pathol 2003;11:11-15 (Pubitemid 36227982)
38. Sheffie MV, Yee H, Dorvault CC, Weiaecher KN, Eltoum SA, Siegal GP et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clinic Pathol 2002;118:930-936 (Pubitemid 37047834)
39. Busam KJ, Iversen K, Coplan KC, Jungbluth AA. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp 100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001;25:197. (Pubitemid 32167501)
40. Salti GI, Manougian T, Farolan M, Shilkaitis A, Majumdar D, Das Gupta TK et al. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res 2000;60:5012.
41. Sheffield MV, Yee H, Dorvault CC, Weilbaecher KN, Eltoum IA, Siegal GP et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol 2002;118:930. (Pubitemid 37047834)